A new survey put a spotlight on the staffing issues rural cardiology practices and health systems face on a daily basis. 

This update comes just months after 11,000 bottles of the same drug were recalled due to a failed test. The FDA has classified this as a Class II recall. 

FastWave Medical's laser intravascular lithotripsy system successfully fractured calcified coronary artery lesions in 30 patients.

A new analysis found that one approach may outperform the other when it comes to minimizing the patient's risk of major cardiovascular events.

The American Heart Association, American College of Cardiology and other U.S. medical societies have collaborated on new recommendations that cover everything from preoperative patient evaluations to postoperative care. 

According to new data from SullivanCotter, compensation in the United States is up more than 20% in the last five years for interventional cardiology, electrophysiology, general cardiology and vascular surgery. This points to a workforce that is getting more competitive over time, one expert told Cardiovascular Business.

“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”

The new software from Chicago-based Tempus AI was designed to identify signs of moderate or severe MR. This is the company's second FDA clearance in the last two months.

The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It covers robotic systems of all types, including those used for various cardiac procedures. 

The new device, which already gained CE mark approval, allows users to switch back and forth from one technique to the other as necessary. 

Pelacarsen, an investigational heart drug developed by Novartis, did successfully reduce Lp(a) levels in high-risk heart patients. However, it was unable to reduce the risk of major adverse cardiovascular events among those patients. 

The new ASNC document includes detailed SPECT- and PET-specific protocols, patient preparation recommendations and a fresh look at safety.

The implementation will span three hospitals in Sweden’s Stockholm Region, supporting between 200,000 and 250,000 breast imaging exams annually. 

A little more than half a year after establishing a healthcare affordability lab, Yale University is out with freshly detailed policy prescriptions for cutting costs without compromising care.